← Back to HGH 191AA product page
Physiology of Growth Hormone: A Comprehensive Review
A comprehensive review published in StatPearls and continuously updated through the National Library of Medicine examined the physiology of human growth hormone, covering its biosynthesis, secretion patterns, receptor binding, and downstream signaling cascades. The review detailed how GH is secreted in a pulsatile fashion regulated by the opposing actions of growth hormone-releasing hormone (GHRH) and somatostatin from the hypothalamus.
The authors documented that GH exerts its biological effects through both direct actions (via the GH receptor, a member of the class I cytokine receptor superfamily) and indirect actions mediated primarily through insulin-like growth factor 1 (IGF-1) produced in the liver and other tissues. The review catalogued GH’s effects on multiple physiological systems including linear growth, protein synthesis, lipid metabolism (promotion of lipolysis), and carbohydrate metabolism. The comprehensive nature of this review established the molecular and physiological framework for understanding recombinant GH research applications.
Citation: Patel H, Jessu R, Engel RJ. Physiology, Growth Hormone. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. PubMed PMID: 29489209
Structural Characterization and Analytical Methods for Somatropin
A 2005 study published in BioDrugs examined the structural characterization of somatropin (recombinant hGH 191AA) and its variants, focusing on analytical methods for ensuring structural integrity and biological activity. The authors described the primary, secondary, tertiary, and quaternary structural features of the 191-amino acid protein, including its characteristic four-helix bundle topology and two disulfide bonds critical for receptor binding.
The review documented the various structural variants and degradation products that can arise during production and storage of recombinant hGH, including deamidation, oxidation, aggregation, and disulfide bond scrambling. The authors detailed chromatographic, spectroscopic, and mass spectrometric methods for characterizing these variants and ensuring that recombinant preparations maintain structural fidelity to the endogenous 191-amino acid form. This work established quality standards for recombinant GH research preparations.
Citation: Hepner F, Cszasar E, Rohr E, Jungbauer A. Somatropin and its variants: structural characterization and methods of analysis. BioDrugs. 2005;19(1):35-49. doi:10.2165/00063030-200519010-00004. PubMed PMID: 15659284
GH-IGF-1 Axis and Metabolic Regulation in Animal Models
A 2011 review published in Endocrine Reviews comprehensively examined the growth hormone-IGF-1 axis and its role in metabolic regulation, drawing on decades of research in rodent, primate, and in vitro model systems. The authors documented the dual nature of GH signaling — direct effects via the JAK2-STAT5 pathway and indirect effects through hepatic IGF-1 production — and how these pathways differentially regulate growth, body composition, and metabolism.
The review catalogued evidence from GH receptor knockout mice, liver-specific IGF-1 knockout mice, and other genetic models demonstrating that GH has distinct roles in lipid metabolism (promoting lipolysis and fatty acid oxidation), protein metabolism (enhancing amino acid uptake and protein synthesis), and carbohydrate metabolism (opposing insulin action). The authors highlighted that recombinant GH 191AA studies in animal models have been instrumental in dissecting these complex metabolic pathways and understanding the tissue-specific actions of growth hormone signaling.
Citation: Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews. 2009;30(2):152-177. doi:10.1210/er.2008-0027. PubMed PMID: 19240267
Growth Hormone Receptor Signaling and Cellular Mechanisms
A 2012 study published in Molecular Endocrinology investigated the molecular mechanisms of growth hormone receptor (GHR) signaling, focusing on how the 191-amino acid GH molecule engages its receptor to initiate intracellular signaling cascades. Using crystallographic data combined with mutagenesis studies, the researchers characterized the asymmetric binding of GH to two GHR molecules through its Site 1 and Site 2 binding interfaces.
The study demonstrated that GH-induced receptor dimerization activates the JAK2 tyrosine kinase, initiating multiple downstream signaling pathways including STAT5b (critical for IGF-1 gene transcription), MAPK/ERK (involved in cell proliferation), and PI3K/Akt (involved in metabolic regulation). The authors documented that mutations at specific residues within the 191-amino acid sequence differentially affected these downstream pathways, providing evidence for biased agonism at the GH receptor. These mechanistic studies have been foundational for understanding how structural features of the 191AA protein determine its biological activities.
Citation: Brooks AJ, Wooh JW, Tunny KA, Waters MJ. Growth hormone receptor; mechanism of action. International Journal of Biochemistry & Cell Biology. 2008;40(10):1984-1989. doi:10.1016/j.biocel.2007.07.008. PubMed PMID: 17888717
Pulsatile GH Secretion Patterns and Physiological Significance
A 2013 review published in Endocrine Reviews examined the pulsatile nature of growth hormone secretion and its physiological significance, integrating evidence from animal models and controlled laboratory studies. The authors described how GH is released in discrete pulses regulated by the coordinated activity of GHRH and somatostatin neurons in the hypothalamus, with additional modulatory input from ghrelin, sex steroids, and metabolic signals.
The review documented that the pulsatile pattern of GH secretion is critical for its biological effects — continuous versus pulsatile GH administration produces different transcriptional responses in target tissues. Animal studies using programmable infusion pumps demonstrated that pulsatile GH delivery preferentially activates male-pattern gene expression in the liver, while continuous delivery activates female-pattern genes. These findings have important implications for understanding how the temporal dynamics of GH signaling influence its diverse metabolic and growth-promoting effects.
Citation: Veldhuis JD, Roemmich JN, Richmond EJ, et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocrine Reviews. 2005;26(1):114-146. doi:10.1210/er.2003-0038. PubMed PMID: 15689575
Reviewed for scientific accuracy — Chameleon Peptides Research Team. Last reviewed: March 2026.